A new paper in Family Practice, published by Oxford University Press, indicates that receiving hormone replacement therapy within six months of a recorded diagnosis of COVID-19 was associated with a reduction in mortality ...
May 17, 2022
0
9
Michelle Butler was just over halfway through her pregnancy when her water broke and contractions wracked her body. She couldn't escape a terrifying truth: Her twins were coming much too soon.
May 11, 2022
0
6
From stem cell therapy to regenerating smell receptors, experts at the University of East Anglia have helped develop a list of research priorities for people with smell and taste disorders.
May 9, 2022
0
6
A new drug has proven beneficial in treating a movement disorder commonly associated with Huntington's disease, according to a recent international study led by UTHealth Houston researcher Erin Furr Stimming, MD, who served ...
Apr 14, 2022
0
0
Depending on where you live, you may have been warned to brace for the next COVID wave, driven by the new Omicron subvariant, more of us being out and about, and fewer people wearing masks.
Apr 8, 2022
0
10
In the first large, randomized head-to-head comparison of two methods of evaluating patients' need for a stent in their coronary artery, patients who were evaluated using a technique that measures blood flow through the artery ...
Apr 4, 2022
0
3
The American College of Cardiology's Global Heart Attack Treatment Initiative (GHATI) reports continuing improvements in quality care delivery for heart attacks in low- and middle-income countries with the use of data collection ...
Apr 4, 2022
0
16
Physicians prescribed significantly more guideline-directed medications for heart failure if they received a customized digital alert via an electronic health record (EHR) system when inputting medical orders shortly after ...
Apr 4, 2022
0
47
Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had significantly lower blood potassium levels when taking patiromer—a drug that helps to prevent the body from absorbing ...
Apr 4, 2022
0
2
Patients with heart failure with reduced ejection fraction (HFrEF) did not experience any improvement in their ability to exercise vigorously after taking the experimental heart failure drug omecamtiv mecarbil, in a study ...
Apr 4, 2022
0
26
